{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:47:56Z","timestamp":1782276476436,"version":"3.54.5"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U34DK123894"],"award-info":[{"award-number":["U34DK123894"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jdiacomp.2026.109275","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T22:48:26Z","timestamp":1769986106000},"page":"109275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inflammatory profile associated with hyperglycemia in children with type 1 diabetes"],"prefix":"10.1016","volume":"40","author":[{"given":"Nicole","family":"Glaser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Chaffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Tancredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arleta","family":"Rewers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Rewers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer","family":"Gilles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Ander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Ghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2026.109275_bb0005","doi-asserted-by":"crossref","first-page":"F716","DOI":"10.1152\/ajprenal.00314.2016","article-title":"Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets","volume":"312","author":"Pichler","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155785","article-title":"Minireview: understanding and targeting inflammatory, hemodynamic and injury markers for cardiorenal protection in type 1 diabetes","volume":"153","author":"Kugathasan","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0015","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2337\/dc17-0867","article-title":"Association between inflammatory markers and progression to kidney dysfunction: examining different assessment windows in patients with type 1 diabetes","volume":"41","author":"Baker","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0020","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2337\/dc17-0509","article-title":"Cardiac stress and inflammatory markers as predictors of heart failure in patients with type 2 diabetes: the ADVANCE trial","volume":"40","author":"Ohkuma","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0025","article-title":"Inflammatory cytokines in diabetic kidney disease: pathophysiologic and therapeutic implications","volume":"22","author":"Donate-Correa","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0030","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/dc13-2112","article-title":"The diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30 years: overview","volume":"37","author":"Nathan","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2021.107880","article-title":"Relationships between inflammation, hemodynamic function and RAAS in longstanding type 1 diabetes and diabetic kidney disease","volume":"35","author":"Ambinathan","year":"2021","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0045","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2337\/db07-1697","article-title":"Association of IL-1ra and adiponectin with C-peptide and remission in patients with type 1 diabetes","volume":"57","author":"Pfleger","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0050","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cyto.2017.07.013","article-title":"Relationship between serum inflammatory markers and vascular function in a cohort of adolescents with type 1 diabetes","volume":"99","author":"Sochett","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2023.05.020","article-title":"Sustained low-grade inflammation in young participants with childhood onset type 1 diabetes: The Norwegian atherosclerosis and childhood diabetes (ACD) study","volume":"379","author":"Simeunovic","year":"2023","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0060","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1210\/jc.2009-1993","article-title":"Inflammatory markers are increased in youth with type 1 diabetes: the SEARCH Case-Control study","volume":"95","author":"Snell-Bergeon","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.atherosclerosis.2014.11.018","article-title":"Inflammation in childhood type 1 diabetes; influence of glycemic control","volume":"238","author":"Heier","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14186511","article-title":"Interleukin-6-related inflammatory burden in type 1 diabetes: evidence for elevation with suboptimal glycemic control","volume":"14","author":"Koufakis","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161548","article-title":"Role of pro-inflammatory cytokines and biochemical markers in the pathogenesis of type 1 diabetes: correlation with age and glycemic condition in diabetic human subjects","volume":"11","author":"Fatima","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11102843","article-title":"Serum cytokines and growth factors in subjects with type 1 diabetes: associations with time in ranges and glucose variability","volume":"11","author":"Klimontov","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0085","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.2337\/dc11-0829","article-title":"Age and sex influence cystatin C in adolescents with and without type 1 diabetes","volume":"34","author":"Maahs","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1176403","article-title":"Excessive BMI is associated with higher C-peptide level at recognition but also with its greater loss in two years clinical observation in children with new onset type 1 diabetes","volume":"14","author":"Kurpiewska","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0095","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.prrv.2006.08.002","article-title":"Obesity and inflammation in children","volume":"7","author":"Schwarzenberg","year":"2006","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0100","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1198\/016214504000001907","article-title":"False discovery rate-adjusted multiple confidence intervals for selected parameters","volume":"100","author":"Benjamini","year":"2005","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0105","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1161\/CIRCRESAHA.119.315896","article-title":"Metabolic inflammation and insulin resistance in obesity","volume":"126","author":"Wu","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0110","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1046\/j.1464-5491.2000.00350.x","article-title":"Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with type 1 diabetes mellitus: relation to glycaemic control and microvascular complications","volume":"17","author":"Chiarelli","year":"2000","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0115","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2337\/dc08-1849","article-title":"Serum monocyte chemoattractant protein-1 concentrations associate with diabetes status but not arterial stiffness in children with type 1 diabetes","volume":"32","author":"Zineh","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0120","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/jpc.15884","article-title":"Toll-like receptor inflammatory cascade and the development of diabetic kidney disease in children and adolescents with type 1 diabetes","volume":"58","author":"de Melo","year":"2022","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0125","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1399-5448.2011.00794.x","article-title":"Increased TLR2 expression in patients with type 1 diabetes: evidenced risk of microalbuminuria","volume":"13","author":"Ururahy","year":"2012","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0130","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1177\/19322968251370298","article-title":"Divergent interleukin-6 responses to hypoglycemia and hyperglycemia in adults with type 1 diabetes: insights from continuous glucose monitoring","volume":"19","author":"Koufakis","year":"2025","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0135","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41591-019-0415-5","article-title":"A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes","volume":"25","author":"Niewczas","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0140","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jdiacomp.2016.06.029","article-title":"Increased levels of inflammatory mediators and proinflammatory monocytes in patients with type I diabetes mellitus and nephropathy","volume":"31","author":"Kolseth","year":"2017","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0145","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1515\/cclm.2011.881","article-title":"Extracellular matrix-associated (GAGs, CTGF), angiogenic (VEGF) and inflammatory factors (MCP-1, CD40, IFN-\u03b3) in type 1 diabetes mellitus nephropathy","volume":"50","author":"Ellina","year":"2012","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12933-015-0195-2","volume":"10","author":"Peeters","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0155","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2023-001583","article-title":"Plasma matrix metalloproteinases and tissue inhibitors of metalloproteinases explored in relation to the severity and progression of diabetic retinopathy in patients with type 1 diabetes: baseline and prospective analyses","volume":"9","author":"Hector","year":"2024","journal-title":"BMJ Open Ophthalmol"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0160","article-title":"Microglia and inflammatory responses in diabetic retinopathy","volume":"6","author":"Kinuthia","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0165","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2337\/dc08-2011","article-title":"Subclinical inflammation and diabetic polyneuropathy: MONICA\/KORA survey F3 (Augsburg, Germany)","volume":"32","author":"Herder","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0170","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.2337\/dc13-0382","article-title":"Association of subclinical inflammation with polyneuropathy in the older population: KORA F4 study","volume":"36","author":"Herder","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0175","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3590389","article-title":"Circulating inflammatory markers are inversely associated with heart rate variability measures in type 1 diabetes","volume":"2020","author":"Wegeberg","year":"2020","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2023.108635","article-title":"Systemic biomarkers of microvascular alterations in type 1 diabetes associated neuropathy and nephropathy - A prospective long-term follow-up study","volume":"37","author":"Baldimtsi","year":"2023","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0185","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-074992","article-title":"Cross-sectional study investigating the association between inflammatory biomarkers and neuropathy in adolescents with type 1 diabetes","volume":"13","author":"Rasmussen","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2024.100328","article-title":"The role of novel inflammation-associated biomarkers in diabetic peripheral neuropathy","volume":"24","author":"Panou","year":"2024","journal-title":"Metabol Open"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0195","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1210\/jc.2008-2385","article-title":"Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy","volume":"94","author":"Doupis","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0200","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s00125-004-1628-8","article-title":"Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB prospective complications study","volume":"48","author":"Schram","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0205","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.2337\/diacare.26.7.2165","article-title":"Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB prospective complications study","volume":"26","author":"Schram","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0210","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neuroscience.2013.04.060","article-title":"Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications","volume":"246","author":"Felger","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107322","article-title":"\u201cInflamed\u201d depression: a review of the interactions between depression and inflammation and current anti-inflammatory strategies for depression","volume":"207","author":"Yin","year":"2024","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1305790","article-title":"Peripheral inflammation and neurocognitive impairment: correlations, underlying mechanisms, and therapeutic implications","volume":"15","author":"Tan","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2016.01.017","article-title":"Chronic peripheral inflammation, hippocampal neurogenesis, and behavior","volume":"58","author":"Chesnokova","year":"2016","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0230","article-title":"The association between depression and type 1 diabetes mellitus: inflammatory cytokines as ferrymen in between?","author":"Wang","year":"2019","journal-title":"Mediators Inflamm."},{"issue":"5","key":"10.1016\/j.jdiacomp.2026.109275_bb0235","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.180226","article-title":"Characterization of cognitive decline in long-duration type 1 diabetes by cognitive, neuroimaging and pathological examinations","volume":"10","author":"Shah","year":"2025","journal-title":"JCI Insight"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0240","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/acn3.51740","article-title":"Predictors of cognitive decline in older individuals without dementia: An updated meta-analysis","volume":"10","author":"Feng","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.jdiacomp.2026.109275_bb0245","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1038\/s41598-025-86309-z","article-title":"Inflammatory biomarkers profiles and cognition among older adults","volume":"15","author":"Thomas","year":"2025","journal-title":"Sci Rep"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872726000206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872726000206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:12:12Z","timestamp":1782274332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872726000206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1056872726000206"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2026.109275","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory profile associated with hyperglycemia in children with type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2026.109275","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"109275"}}